345 related articles for article (PubMed ID: 31279179)
1. Recent advances in biosensor for detection of lung cancer biomarkers.
Yang G; Xiao Z; Tang C; Deng Y; Huang H; He Z
Biosens Bioelectron; 2019 Sep; 141():111416. PubMed ID: 31279179
[TBL] [Abstract][Full Text] [Related]
2. Recent Progress in Biosensors for Detection of Tumor Biomarkers.
Li M; Jiang F; Xue L; Peng C; Shi Z; Zhang Z; Li J; Pan Y; Wang X; Feng C; Qiao D; Chen Z; Luo Q; Chen X
Molecules; 2022 Oct; 27(21):. PubMed ID: 36364157
[TBL] [Abstract][Full Text] [Related]
3. Early detection of lung cancer biomarkers through biosensor technology: A review.
Roointan A; Ahmad Mir T; Ibrahim Wani S; Mati-Ur-Rehman ; Hussain KK; Ahmed B; Abrahim S; Savardashtaki A; Gandomani G; Gandomani M; Chinnappan R; Akhtar MH
J Pharm Biomed Anal; 2019 Feb; 164():93-103. PubMed ID: 30366148
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer.
Lee JH; Chang JH
Chest; 2005 Oct; 128(4):2298-303. PubMed ID: 16236887
[TBL] [Abstract][Full Text] [Related]
5. Carcinoembryonic antigen, neuron-specific enolase and cytokeratin fragment 19 (CYFRA 21-1) levels in induced sputum of lung cancer patients.
Hillas G; Moschos C; Dimakou K; Vlastos F; Avgeropoulou S; Christakopoulou I; Rasidakis A; Bakakos P
Scand J Clin Lab Invest; 2008; 68(7):542-7. PubMed ID: 19378425
[TBL] [Abstract][Full Text] [Related]
6. Bead-based microarray immunoassay for lung cancer biomarkers using quantum dots as labels.
Liu L; Wu S; Jing F; Zhou H; Jia C; Li G; Cong H; Jin Q; Zhao J
Biosens Bioelectron; 2016 Jun; 80():300-306. PubMed ID: 26852198
[TBL] [Abstract][Full Text] [Related]
7. Electrochemical biosensors for the detection of lung cancer biomarkers: A review.
Khanmohammadi A; Aghaie A; Vahedi E; Qazvini A; Ghanei M; Afkhami A; Hajian A; Bagheri H
Talanta; 2020 Jan; 206():120251. PubMed ID: 31514848
[TBL] [Abstract][Full Text] [Related]
8. Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study.
Ebert W; Dienemann H; Fateh-Moghadam A; Scheulen M; Konietzko N; Schleich T; Bombardieri E
Eur J Clin Chem Clin Biochem; 1994 Mar; 32(3):189-99. PubMed ID: 7518259
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of the tumour markers, carcinoembryonic antigen (CEA), cytokeratin marker (CYFRA 21-1) and neuron-specific enolase (NSE) in the differentiation of malignant from benign solitary pulmonary lesions.
Seemann MD; Beinert T; Fürst H; Fink U
Lung Cancer; 1999 Dec; 26(3):149-55. PubMed ID: 10598925
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of serum tumor markers in patients with lung cancer.
Hatzakis KD; Froudarakis ME; Bouros D; Tzanakis N; Karkavitsas N; Siafakas NM
Respiration; 2002; 69(1):25-9. PubMed ID: 11844959
[TBL] [Abstract][Full Text] [Related]
11. [Usefulness and limitation of serum tumor markers in diagnosis of lung cancer].
Fukuda M; Oka M
Nihon Rinsho; 1996 Jun; 54(6):1610-5. PubMed ID: 8691617
[TBL] [Abstract][Full Text] [Related]
12. Highly sensitive detection of multiple tumor markers for lung cancer using gold nanoparticle probes and microarrays.
Gao W; Wang W; Yao S; Wu S; Zhang H; Zhang J; Jing F; Mao H; Jin Q; Cong H; Jia C; Zhang G; Zhao J
Anal Chim Acta; 2017 Mar; 958():77-84. PubMed ID: 28110687
[TBL] [Abstract][Full Text] [Related]
13. Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases.
Schneider J; Philipp M; Velcovsky HG; Morr H; Katz N
Anticancer Res; 2003; 23(2A):885-93. PubMed ID: 12820318
[TBL] [Abstract][Full Text] [Related]
14. Electrochemical biosensors for measurement of colorectal cancer biomarkers.
Zhang W; Xiao G; Chen J; Wang L; Hu Q; Wu J; Zhang W; Song M; Qiao J; Xu C
Anal Bioanal Chem; 2021 Apr; 413(9):2407-2428. PubMed ID: 33666711
[TBL] [Abstract][Full Text] [Related]
15. Early lung cancer diagnosis by biosensors.
Zhang Y; Yang D; Weng L; Wang L
Int J Mol Sci; 2013 Jul; 14(8):15479-509. PubMed ID: 23892596
[TBL] [Abstract][Full Text] [Related]
16. Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patients.
Pujol JL; Boher JM; Grenier J; Quantin X
Lung Cancer; 2001; 31(2-3):221-31. PubMed ID: 11165401
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of seven tumour markers in lung cancer diagnosis: can any combination improve the results?
Plebani M; Basso D; Navaglia F; De Paoli M; Tommasini A; Cipriani A
Br J Cancer; 1995 Jul; 72(1):170-3. PubMed ID: 7541234
[TBL] [Abstract][Full Text] [Related]
18. Multiplexed detection of lung cancer biomarkers based on quantum dots and microbeads.
Wu S; Liu L; Li G; Jing F; Mao H; Jin Q; Zhai W; Zhang H; Zhao J; Jia C
Talanta; 2016 Aug; 156-157():48-54. PubMed ID: 27260434
[TBL] [Abstract][Full Text] [Related]
19. Clinical observations on the association between diagnosis of lung cancer and serum tumor markers in combination.
Wang WJ; Tao Z; Gu W; Sun LH
Asian Pac J Cancer Prev; 2013; 14(7):4369-71. PubMed ID: 23992005
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility of haptoglobin in combination with CEA, NSE and CYFRA21-1 for diagnosis of lung cancer.
Wang B; He YJ; Tian YX; Yang RN; Zhu YR; Qiu H
Asian Pac J Cancer Prev; 2014; 15(22):9611-4. PubMed ID: 25520076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
